Vildagliptin
DrugBank ID: DB04876
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| classic stiff person syndrome | 0.9988 | DL |
| focal stiff limb syndrome | 0.9988 | DL |
| diabetes mellitus (disease) | 0.9988 | KG+DL |
| thiamine-responsive dysfunction syndrome | 0.9987 | DL |
| opsismodysplasia | 0.9986 | DL |
| drug-induced localized lipodystrophy | 0.9979 | DL |
| centrifugal lipodystrophy | 0.9978 | DL |
| pressure-induced localized lipoatrophy | 0.9978 | DL |
| idiopathic localized lipodystrophy | 0.9976 | DL |
| pancreatic agenesis | 0.9975 | DL |
| type 1 diabetes mellitus | 0.9937 | DL |
| autoimmune oophoritis | 0.9933 | DL |
| permanent neonatal diabetes mellitus | 0.8802 | DL |
| diabetes mellitus, insulin-dependent, X-linked, susceptibility to | 0.8640 | DL |
| diabetic ketoacidosis | 0.8380 | DL |
| hemoglobin C-beta-thalassemia syndrome | 0.6767 | DL |
| cholangiocarcinoma, susceptibility to | 0.6733 | DL |
| hypercarotenemia and vitamin A deficiency, autosomal recessive | 0.6700 | DL |
| atrial flutter (disease) | 0.6602 | DL |
| IDDM 1 | 0.6359 | DL |
| pancreas, dorsal, agenesis of | 0.6273 | DL |
| lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis | 0.6211 | DL |
| familial chronic myelocytic leukemia-like syndrome | 0.6173 | DL |
| corneal degeneration, band-shaped spheroid | 0.6069 | DL |
| congenital temporomandibular joint ankylosis | 0.6038 | DL |
| radiation proctitis | 0.6017 | DL |
| melanoma, malignant familial intraocular | 0.6006 | DL |
| ovarian fibroma (disease) | 0.5997 | DL |
| abdominal obesity-metabolic syndrome quantitative trait locus 2 | 0.5992 | DL |
| Polymerase proofreading-related adenomatous polyposis | 0.5985 | DL |
| prostate cancer, hereditary, X-linked | 0.5980 | DL |
| trichoepitheliomas, multiple desmoplastic | 0.5965 | DL |
| hyperparathyroidism, primary, caused by water clear cell hyperplasia | 0.5932 | DL |
| Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin | 0.5910 | DL |
| anuria | 0.5907 | DL |
| fibrosis of extraocular muscles, congenital, with synergistic divergence | 0.5903 | DL |
| giant neutrophil leukocytes | 0.5886 | DL |
| hypospadias 3, autosomal | 0.5886 | DL |
| sella turcica, bridged | 0.5886 | DL |
| triphalangeal thumb, Nonopposable | 0.5886 | DL |
| avascular necrosis | 0.5881 | DL |
| lymphatic malformation 8 | 0.5873 | DL |
| mitral valve prolapse, myxomatous | 0.5861 | DL |
| syncope, familial vasovagal | 0.5857 | DL |
| obsolete functional visual loss | 0.5850 | DL |
| benign cephalic histiocytosis | 0.5845 | DL |
| nonarteritic anterior ischemic optic neuropathy, susceptibility to | 0.5825 | DL |
| obsolete breast fibroadenosis | 0.5811 | DL |
| obsolete superimposed infection | 0.5810 | DL |
| sudden arrhythmia death syndrome | 0.5784 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.